[Monoclonal gammapathy of indeterminate origin and myeloma].
Bury
J
J
Salmon
J
J
Fillet
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006942:Hypergammaglobulinemia / Q000175:diagnosis / Q000209:etiology; D007370:Interferon Type I / Q000627:therapeutic use; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis / Q000209:etiology; D009101:Multiple Myeloma / Q000175:diagnosis / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D007370:Interferon Type I; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone; D008775:Methylprednisolone
Gammapathie monoclonale d'origine indéterminée et myélome.